好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Lipoprotein, Blood Pressure and Stroke Risk: Findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study
Cerebrovascular Disease and Interventional Neurology
(-)
001
Authors/Disclosures
Pierre Amarenco, MD Dr. Amarenco has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AstraZeneca. Dr. Amarenco has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Amarenco has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS. The institution of Dr. Amarenco has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pfizer. Dr. Amarenco has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for KOWA company.
Larry B. Goldstein, MD, FAHA, FAAN (University of Kentucky) The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from Janssen. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Rosanne Govaarts, MSc (Amsterdam University Medical Centers) Ms. Govaarts has nothing to disclose.
No disclosure on file
Amy Rudolph No disclosure on file
No disclosure on file
K. M. Welch, MB, ChB, FRCP (Rosalind Franklin Univ of Medicine And Science) No disclosure on file
No disclosure on file